Medication info

Levothyroxine Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Ankuk Pharmaceuticals Co., Ltd.
Appearance
A double-coated tablet that is oval-shaped and convex on both sides, white and light gray in color.
Packaging
30 tablets/box [10 tablets/Alu-Alu X 3]
Approval status
Active

MFDS item code 202202672 · Approved 2022.06.27

Summary

Main use
Treatment of essential hypertension not adequately controlled with amlodipine or telmisartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosing regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients requiring cautious administration'). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Ankuk Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with amlodipine or telmisartan monotherapy

  • Essential hypertension
View approved original text

Used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosing regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients requiring cautious administration'). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can pose a serious risk to the fetus, especially during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. This medication should not be administered to patients with certain conditions, such as those with severe liver impairment or heart disease. Patients with primary aldosteronism or renal impairment need to be especially cautious when using this medication. Side effects such as dizziness or peripheral edema can commonly occur during treatment, and severe side effects have been reported rarely. It is recommended to avoid using this medication during pregnancy, and if planning to conceive or currently pregnant, consult a physician. Hypotension may occur, so patients should replenish fluids or sodium if they are deficient before taking the medication, or adjust the dose as directed by a doctor. There is a risk of increased blood potassium levels, so patients at risk for hyperkalemia should have regular blood tests. Patients with renal impairment should have regular checks on renal function and electrolyte levels while using this medication. In patients with cardiovascular diseases, this medication may increase the risk of angina or myocardial infarction, so caution is necessary. Drowsiness or dizziness may occur while taking this medication, so driving or operating dangerous machinery should be approached with care. Interactions with other medications may occur, so if on any additional medications, it is crucial to inform a doctor or pharmacist. Elderly patients may be more sensitive to this medication, so it is advisable to start at a lower dose and gradually increase. In cases of overdose, symptoms such as hypotension, dizziness, and heart function deterioration may appear, and immediate medical attention should be sought. This medication is not recommended for children as safety and effectiveness have not been established.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • septicemia
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • altered sensation
  • decreased sensation
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal gas retention
  • vomiting
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container that protects it from light, and the storage temperature should be maintained at room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

A double-coated tablet that is oval-shaped and convex on both sides, white and light gray in color.

Package unit

30 tablets/box [10 tablets/Alu-Alu X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.